chr7:55086794:> Detail (hg19) (EGFR)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr7:55,086,794-55,279,321 |
hg38 | chr7:55,019,101-55,211,628 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
Disease | Drug | EL | ET | ED | CS | VO | TR | Pubmed | Links |
---|---|---|---|---|---|---|---|---|---|
lung adenocarcinoma | B |
![]() |
![]() |
Better Outcome | Somatic | 4 | 22810899 | Detail | |
lung non-small cell carcinoma | Afatinib | B |
![]() |
![]() |
Sensitivity/Response | Somatic | 4 | 27083334 | Detail |
lung non-small cell carcinoma | Gefitinib | B |
![]() |
![]() |
Sensitivity/Response | Somatic | 5 | 20022809 | Detail |
lung non-small cell carcinoma | Gefitinib,Erlotinib | B |
![]() |
![]() |
Sensitivity/Response | Somatic | 4 | 21258250 | Detail |
lung non-small cell carcinoma | Gefitinib | C |
![]() |
![]() |
Sensitivity/Response | Somatic | 19692680 | Detail | |
lung non-small cell carcinoma | Afatinib | C |
![]() |
![]() |
Sensitivity/Response | Somatic | 22452896 | Detail | |
lung non-small cell carcinoma | Gefitinib | B |
![]() |
![]() |
Sensitivity/Response | Somatic | 3 | 15329413 | Detail |
lung cancer | Gefitinib | B |
![]() |
![]() |
Sensitivity/Response | Somatic | 2 | 17409929 | Detail |
lung non-small cell carcinoma | Gefitinib | B |
![]() |
![]() |
Sensitivity/Response | 3 | 20038723 | Detail | |
lung adenocarcinoma | B |
![]() |
![]() |
Better Outcome | Somatic | 3 | 21969500 | Detail | |
lung non-small cell carcinoma | Erlotinib | B |
![]() |
![]() |
Sensitivity/Response | Somatic | 3 | 15329413 | Detail |
lung non-small cell carcinoma | Erlotinib | C |
![]() |
![]() |
Sensitivity/Response | Somatic | 4 | 21969500 | Detail |
peritoneal mesothelioma | Cytoreductive Surgery,Hyperthermic Intraperitoneal Chemotherapy | B |
![]() |
![]() |
Sensitivity/Response | Somatic | 4 | 20942962 | Detail |
lung non-small cell carcinoma | Erlotinib | B |
![]() |
![]() |
Sensitivity/Response | Somatic | 4 | 21783417 | Detail |
lung non-small cell carcinoma | Dacomitinib | B |
![]() |
![]() |
Sensitivity/Response | Somatic | 4 | 28958502 | Detail |
DisGeNET
[No Data.]
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
In a study of 1036 patients with lung adenocarcinomas, patients with EGFR mutations (n=275) showed b... | CIViC Evidence | Detail |
In the LUX-LUNG 7 trial, (NCT01466660) stage IIIB or IV NSCLC patients with EGFR exon 19 deletion, (... | CIViC Evidence | Detail |
This open label Phase 3 Trial performed across 36 centers in Japan (WJTOG3405) assessed patients wit... | CIViC Evidence | Detail |
In a retrospective study, 166 non-small cell lung cancer (NSCLC) patients that tended to have select... | CIViC Evidence | Detail |
In a phase 3 clinical trial of East Asian advanced pulmonary adenocarcinoma patients, a subset of pa... | CIViC Evidence | Detail |
In a phase 2b/3 study of 585 stage IIIB-IV lung adenocarcinoma patients who had a previous round of ... | CIViC Evidence | Detail |
Mutational profiling was performed on EGFR exons 18-24 from a group of 10 retrospectively chosen pat... | CIViC Evidence | Detail |
In a study of 52 patients with recurrent lung cancer, 27 individuals had EGFR mutation including 2 p... | CIViC Evidence | Detail |
In a phase 3 clinical trial of non-small cell lung cancer (NSCLC) patients, a subset of patients wit... | CIViC Evidence | Detail |
Analysis was performed on the placebo group (n=451) of the Phase III study SATURN using erlotinib ma... | CIViC Evidence | Detail |
In a phase II trial for Bronchioloalveolar carcinoma (BAC, or in situ pulmonary adenocarcinoma), EGF... | CIViC Evidence | Detail |
In the placebo-controlled Phase III study SATURN, using erlotinib maintenance therapy for patients w... | CIViC Evidence | Detail |
25 patients with metastatic peritoneal mesothelioma were treated with surgical cytoreduction consoli... | CIViC Evidence | Detail |
In this open-label, randomised, phase 3 trial at 22 centres in China, patients with stage IIIB or IV... | CIViC Evidence | Detail |
In the ARCHER 1050 Phase 3 Trial (NCT01774721), 452 patients with newly diagnosed stage IIIB/IV or r... | CIViC Evidence | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- Genome
- hg19
- Position
- chr7:55,086,794-55,279,321
- Variant Type
- snv
- Variant (CIViC) (CIViC Variant)
- MUTATION
- Transcript 1 (CIViC Variant)
- ENST00000275493.2
- Variant URL (CIViC Variant)
- https://civic.genome.wustl.edu/links/variants/442
Genome browser